Mitochondrial sensitivity to AZT

Cell Biochemistry and Function

Volumn 16, Issue 3, 1998, Pages 173-181

  Pereira, Luiz Fernando ^a,b   Oliveira, Maria Benigna M ^a   Carnieri, Eva Gunilla S ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

AZT; Bioenergetics; Mitochondrial disease

Indexed keywords

GLUTAMIC ACID; MITOCHONDRIAL ENZYME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; BREATHING; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HEART MUSCLE; KIDNEY; LIVER MITOCHONDRION; MALE; MUSCLE; MUSCLE MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SKELETAL MUSCLE; TISSUE SPECIFICITY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT; KIDNEY; MALE; MITOCHONDRIA; MITOCHONDRIA, HEART; MITOCHONDRIA, LIVER; MITOCHONDRIA, MUSCLE; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; NADH, NADPH OXIDOREDUCTASES; OXYGEN CONSUMPTION; PROTON-TRANSLOCATING ATPASES; RATS; RATS, WISTAR; SUCCINIC ACID; ZIDOVUDINE;

ANIMALIA;

EID: 0031667783     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0844(199809)16:3<173::AID-CBF783>3.0.CO;2-4     Document Type: Article

References (57)

1. Mitsuya, H., Weinhold, K. J., Furman, P. A., St. Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W. and Broder, S. (1985). 3′-Azido-3′-Deoxythymidine (BWA509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T - lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. U.S.A., 82, 7096-7100.
2. Mitsuya, H., Yarchoan, R. and Broder, S. (1990). Molecular targets for AIDS therapy Science, 249, 1533-1544.
3. Abbas, A. K., Lichtman, A. H., Pobers, J. S. (1991). IV. Immunity in defense and disease. In: Cellular and Molecular Immunology, (Saunders, W. B., ed.) Philadelphia, pp. 386-395.
4. Balzarini, J., Pauwels, R., Baba, M., Herdewijn, P., Declerq, E., Broder, S. and Johns, D. G. (1988). The in vitro and in vivo anti-retrovirus activity and intracellular metabolism of 3′azido-2′,3′ dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem. Pharmacol., 37, 897-903.
5. Frick, L. W., Nelson, D. J., St. Clair, M. H., Furman, P. A. and Krenitsky, T. A. (1988) Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem. Biophys. Res. Comm., 154, 124-129.
6. Yarchoan, R., Mitsuya, H., Myers, C. E. and Broder, S. (1989). Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine and related dideoxynucleosides). N. Engl. J. Med., 321, 726-738.
7. van Wijk, G. M. T., Hostetler, K. Y. and van den Bosch, H. (1991). Lipid conjugates of antiretroviral agents: release of antiretroviral nucleoside monophosphates by a nucleoside diphosphate diglyceride hydrolase activity from rat liver mitochondria. Biochim. Biophys. Acta, 1084, 307-310.
8. Neuzil, K. M. (1994). Pharmacologic therapy for human immunodeficiency virus infection: a review. Am. J. Med. Sci., 307, 368-373.
9. Simpson, M. V., Chin, C. D., Keilbaugh, S. A., Lin, T-S. and Prusoff, W. H. (1989). Studies on the inhibition of mitochondria DNA replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication. Biochem. Pharmacol., 38, 1033-1036.
10. American Hospital Formulary Service (AHFS) (1994). Zidovudine. American Society of Hospital Pharmacists: Bethesda, pp. 392-401.
11. Yarchoan, R., Mitsuya, H. and Broder, S. (1993). Challenges in the therapy of HIV infection. Trends Pharmacol. Sci., 14, 196-202.
12. Darke, P. L. and Huff, J. R. (1994). HIV protease as an inhibitor target for the treatment of AIDS. Adv, Pharmacol., 25, 399-454.
13. Rice, W. G. and Bader, J. P. (1995). Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals. Adv. Pharmacol, 33, 389-438.
14. Zimmerman, T. P., Mahony, W. B. and Prus, K. L. (1987). 3′-Azido-3′-deoxythymidine: An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. J. Biol. Chem., 262, 5748-5754.
15. Mhiri, C., Baudrimont, M., Bonne, G., Geny, C., Degoul, F., Marsac, C., Roullet, E. and Gherardi, R. (1991). Zidovudine myopathy; a distinctive disorder associated with mitochondrial dysfunction. Ann. Neural., 29, 606-614.
16. Peters, B. S., Winer, J., Landon, D. N., Stotter, A. and Pinching, A. J. (1993). Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Q. J. Med., 86, 5-15.
17. Dalakas, M. C., Leon-Monzon, M. E., Beraardini, I., Gahl, W. A. and Jay, C. A. (1994). Zidovudine-mduced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann. Neurol., 35, 482-487.
18. Semino-Mora, M. C., Leon-Monzon, M. E. and Dalakas, M. C. (1994). Effects of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: carnitine prevents the myotoxicity of AZT in vitro. Lab. Invest., 71, 102-112.
19. Lamperth, L., Dalakas, M. C., Dagani, F., Anderson, J. and Ferrari, R. (1991). Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest., 65, 742-751.
20. Dalakas, M. C., Illa, J , Pezeshkpour, G. H., Laukaitis, J. P., Cohen, B., and Griffin, J. L. (1990). Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med., 322, 1098-1105.
21. Lewis, W., Papoian, T., Gonzalez, B., Louie, H., Kelly, D. P., Payne, M. and Grody, W. W. (1991). Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab. Invest., 65, 228-236.
22. Lewis, W., Gonzalez, B., Chomyn, A. and Papoian, T. (1992). Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J. Clin. Invest., 89, 1354-1360.
23. Lewis, W., Simpson, J. F. and Meyer, R. R (1994). Cardiac mitochondria DNA polymerase-γ is inhibited competitively and noncompetitively by phosphorylated zidovudine. Circ. Res., 74, 344-348.
24. Lewis, W. and Dalakas, M. C. (1995). Mitochondrial toxicity of antiviral drugs. Nature Med., 1, 417-422.
25. Modica-Napolitano, J. S. (1993). AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem. Biophys. Res. Comm , 194, 170-177.
26. Hobbs, G. A., Keilbaugh, S. A., Rief, P. M. and Simpson, M V. (1995). Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation. Biochem. Pharmacol., 50, 381-390.
27. Rajaonarison, J. F., Lacarelle, B., Catalin, J., Durand, A. and Cano, J. P. (1993). Effects of anticancer drugs on the glucuronidation of 3′-azido-3′-deoxythymidine in human liver microsomes. Drug Metab. Dispos., 21, 823-829.
28. Eagling, V A., Howe, J. L., Barry, M. J. and Back, D J. (1994). The metabolism of zidovudine by human liver microsomes in vitro: formation of 3′-amino-3′-deoxythymidine. Biochem. Pharmacol., 48, 267-276.
29. Schröder, J M., Kaldenbach, T. and Werner, P. (1996). Nuclear and mitochondrial changes of co-cultivated spinal cord, spinal ganglia and muscle fibers following treatment with various doses of zidovudine. Act Neuropathol., 92, 138-149.
30. Singer, T. P., Ramsay, R. R. and Ackrell, B. A. C. (1995). Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies. Biochim. Biophys. Acta, 1271, 211-219.
31. Voss, D. O., Campello, A. P. and Bacila, M. (1961). The respiratory chain and the phosphorylation of rat brain mitochondria. Biochem. Biophys. Commun., 4, 48-51.
32. Jung, K., Reinholdt, C and Scholz, D. (1987). Inhibited efficiency of kidney mitochondria isolated from rats treated with cyclosporin A. Nephron, 45, 43-45.
33. Estabrook, R. W. (1967). Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Methods Enzymol., 10, 41-47.
34. Chance, B. and Williams, G. R (1955). The respiratory enzymes in oxidative phosphorylation: kinetics of oxygen utilization. J. Biol. Chem., 217, 383-393.
35. Singer, T. P. (1974). Determination of the activity of succinate, NADH, choline and α-glycerophosphate dehydrogenase. In: Methods in Biochemical Analysis, Vol. 22. John Wiley & Sons: New York, pp. 231-237.
36. Pullman, M. E., Penefsky, H. S., Datta, A. and Racker, E. (1960). Partial resolution of the enzymes catalyzing oxidative phosphorylation I: Purification and properties of soluble, dinitrophenol stimulated triphosphate. J. Biol. Chem., 235(11), 3322-3329
37. Lowry, O. H., Resenbrough, N. J., Farr, A. C. and Randall, R. J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275
38. Chariot, P., Monnet, I. and Gherardi, R. (1993). Cytochrome C oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann. Neurol., 34, 561-565.
39. Walker, J. E. (1995). Determination of the structures of respiratory enzyme complexes from mammalian mitochondria. Biochim. Biophys. Acta, 1271, 221-227.
40. Finel, M., Skenel, M., Albracht, S. P. J., Fearnley, I. M. and Walker, J. E. (1992). Resolution of NADH: ubiquinone oxidoreductase from bovine heart mitochondria into two subcomplexes, one of which contains the redox centers of the enzyme Biochemistry, 31, 11425-11434.
41. Weiss, H., Friedrich, T., Hofhaus, G. and Preis, D. (1991). The respiratory-chain NADH dehydrogenase (complex I) of mitochondria Eur. J. Biochem., 197, 563-576.
42. Reardon, J. E., Crouch, R. C. and John-Williams, L. St. (1994). Reduction of 3′-azido-3′-deoxythymidine (AZT) and AZT nucleotides by thiols. J. Biol. Chem., 23, 15999-16008.
43. Genchi, G., Petrone, G., De Palma, A., Cambria, A. and Palmieri, F. (1988) Interaction of phenylisothiocyanates with the mitochondrial phosphate carrier. I. Covalent modification and inhibition of phosphate transport. Biochim. Biophys. Acta, 936, 413-420.
44. + with the mitochondrial NADH dehydrogenase. J. Biol Chem., 16, 8318-8323.
45. Earley, F G. P. and Ragan, C. I. (1984). Photoaffinity labelling of mitochondrial NADH dehydrogenase with arylazidomorphigenin, an analogue of rotenone. Biochem. J., 224, 525-534.
46. 32P] diphosphate. Biochemistry, 24, 7372-7379.
47. Linnane, A. W , Esposti, M. D., Generowics, M., Luff, A. R. and Nagley, P. (1995). The universality of bioenergetic disease and amelioration with redox therapy. Biochim. Biophys. Acta, 1271, 191-194.
48. 10) on muscular dystrophies and neurogenic atrophies. Biochem. Biophys. Acta, 1271, 281-286.
49. Ernster, L. and Dallner, G. (1995). Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophvs. Acta, 1271, 195-204.
50. Sluse, F. E., Meijer, A. J. and Tager, J. M. (1971). Anion translocators in rat-heart mitochondria. FEBS Lett., 18, 149-153.
51. Palmieri, F., Quagliariello, E. and Klingenberg, M. (1972). Kinetics and specificity of oxoglutarate carrier in rat-liver mitochondria. Eur. J. Biochem., 29, 408-416.
52. Indiven, C., Capobianco, L., Krämer, P. and Palmieri, F. (1989). Kinetics of the reconstituted dicarboxylate carrier from rat liver mitochondria. Biochim. Biophys. Acta, 977, 87-193.
53. 32P)adenosine diphosphate. Biochemistry, 27, 5141-5149.
54. Klingenberg, M. (1989). Molecular aspects of the adenine nucleotide carrier from mitochondria. Arch. Biochem. Biophys, 270, 1-14.
55. Barile, M., Valenti, D., Hobbs, G. A., Abruzze, M. F., Keilbaugh, S. A., Passarella, S., Quagliariello, E. and Simpson, M. V. (1994). Mechanisms of toxicity of 3′-azido-3′-deoxythymidine; Its interaction with adenylate kinase. Biochem. Pharmacol., 48, 1405-1412.
56. 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV infected patients. Neurology, 42, 619-623.
57. McCurdy III, D. T. and Kennedy, J. M. (1996). Skeletal muscle mitochondria from AZT treated rats have a diminished response to chronic electrical stimulation. J. Appl. Physiol., 81, 326-334.